Abstract
Bohring-Opitz syndrome (BOS) is a rare congenital disorder of unknown etiology diagnosed on the basis of distinctive clinical features. We suggest diagnostic criteria for this condition, describe ten previously unreported patients, and update the natural history of four previously reported patients. This is the largest series reported to date, providing a unique opportunity to document the key clinical features and course through childhood. Investigations undertaken to try and elucidate the underlying pathogenesis of BOS using array comparative genomic hybridization and tandem mass spectrometry of cholesterol precursors did not show any pathogenic changes responsible.
| Original language | English |
|---|---|
| Journal | European Journal of Human Genetics |
| Volume | 19 |
| Issue number | 5 |
| Pages (from-to) | 513-519 |
| Number of pages | 7 |
| ISSN | 1018-4813 |
| DOIs | |
| Publication status | Published - 01.05.2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Bohring-Opitz (Oberklaid-Danks) Syndrome: Clinical study, review of the literature, and discussion of possible pathogenesis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver